Altium Capital Management LLC / NGNE
Altium Capital Management LLC’s Neurogene Inc Position
Does Altium Capital Management LLC own Neurogene Inc (NGNE)? Not currently — the last reported position was 100.0K shares worth $5M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q1 2024
Shares
100.0K
% of Portfolio
+2.01%
Quarters Held
2
position exited
Position History NGNE
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of NGNE.